FDA approves suzetrigine, first non-opioid painkiller authorized in many years

How this drug works

When electric alerts float during the nerve cells, suzetrigine necessarily “opens” and “closes” sodium channels to permit sodium ions to go via. This then activates nerve impulses to transmit ache alerts to the mind. Even if procaine (Novocain) is an efficient and dependable anesthetic (and sodium-channel-targeting drug), it should be administered in the neighborhood via injections, lotions, or gels.¹

Promising medical trial effects

Following the result of a success section III trials introduced at a 2024 anesthesiology convention, researchers concluded that: “[suzetrigine] has the prospective to be a secure and efficient non-opioid remedy possibility for average to serious acute ache and the prospective to be the primary drug in a brand new magnificence of ache.”¹

One player on this trial, Terp Vairin, reported feeling lucid after taking suzetrigine to ease any ache and discomfort brought about by means of their surgical procedure. They didn’t revel in any grogginess or nausea usually related with opioid use. If truth be told, greater than 80% of trial members rated suzetrigine simply as efficient as post-surgery opioid regimen-with considerably fewer uncomfortable side effects. It even outperformed placebos in lots of protection measures.¹

Long run hurdles

Jessica Oswald, a pain-medicine specialist on the College of California believes suzetrigine is also a viable choice to opioids someday. On the other hand, the good fortune of this drug, and its skill to supersede opioids, will depend on the associated fee.

As of presently, the wholesale worth is round $15.50 consistent with tablet, which is costlier than maximum opioids-but it can be cheaper ultimately because of the long health-care prices brought about by means of opioid habit.

Moreover, there’s a urgent want for opioid choices in a protracted ache environment, and presently, suzetrigine simplest works in treating acute ache. LTG-001, a drug evolved by means of Latigo Biotherapeutics in Thousand Oaks, California, may be present process medical trials yet is also much more efficient in treating serious ache. In comparison to suzetrigine’s two-to-four-hour absorption time, LTG-001 “kicks in” sooner and will subsequently supply extra fast ache aid.¹

Both means, suzetrigine’s early good fortune is one thing to be celebrated-it’s a promising step ahead in combating the opioid disaster.

References

1. US drug company approves potent painkiller – the primary non-opioid in many years. Nature. January 31, 2025. https://www.nature.com/articles/d41586-025-00274-1?utm_source=Reside+Target audience&utm_campaign=7f8f44a224-nature-briefing-daily-20250131&utm_medium=e-mail&utm_term=0_b27a691814-7f8f44a224-51429308

2. Opioid disaster: habit, overprescription, and inadequate number one prevention. Lancet Reg Well being Am. 2023 Jul 12;23:100557. doi: 10.1016/j.lana.2023.100557.